SQLite Web: event_store.db

Update row sig_5e99415e9f59 in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt","company":"Serina Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt","article_chars":1646,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_c34ea29380d16996","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:31:36.415056+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt","source_event_id":"evt_c7cbe3a7efea","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"fd4aef12f989f402","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-21","2026-03-31","2025-04-08","2017-06-06"],"entities":[{"asset_class":"equity","name":"Serina Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"Venkatesan Jay","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Common Stock","relevance":"high","symbol":"","type":"security"},{"asset_class":"equity","name":"Convertible Preferred Stock","relevance":"medium","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; no prior filing/position baseline is included.","The filing excerpt does not clearly specify whether the transaction is an increase/decrease in holdings beyond the statement that shares were issued for accrued dividends.","The excerpt includes \u201c7553\u201d and \u201c1.94\u201d but the exact mapping (e.g., shares vs. price vs. other fields) is not fully explained in the provided text.","No explicit prior holdings, post-transaction ownership totals, or transaction type code details are included in the cleaned text."],"key_facts":["SEC filing: Form 4 (SEC Act: 1934 Act; SEC file number 001-38519)","Issuer: Serina Therapeutics, Inc. (CIK 0001708599)","Reporting owner: Venkatesan Jay (CIK 0001413350)","Conformed period of report: 2026-03-31","Filed as of date: 2026-04-21 (accession number 0001413350-26-000002)","The filing text states: \u201cThese shares of common stock were issued for payment of accrued dividends on the reporting individuals\u201d","The filing text also states: \u201cA Convertible Preferred Stock issued on April 8, 2025.\u201d"],"numeric_claims":[{"label":"Conformed period of report","value":"2026-03-31"},{"label":"Filed as of date","value":"2026-04-21"},{"label":"Convertible Preferred Stock issuance date referenced","value":"2025-04-08"},{"label":"Number of shares (as shown)","value":"7553"},{"label":"Price (as shown)","value":"1.94"}],"primary_claim":"Form 4 for Serina Therapeutics, Inc. was filed on 2026-04-21 by reporting owner Jay Venkatesan, stating the common stock shares were issued for payment of accrued dividends related to a convertible preferred stock issued on April 8, 2025.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Serina Therapeutics, Inc. filed a Form 4 on 2026-04-21 reporting a transaction by reporting owner Jay Venkatesan. The filing states the shares were issued for payment of accrued dividends and references a convertible preferred stock issued on April 8, 2025.","topics":["SEC Form 4","insider transaction","accrued dividends","convertible preferred stock","ownership/issuance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Serina Therapeutics, Inc. \u00b7 Filed 20260421","ticker":"SER","tickers":["SER"],"title":"SER filed 4","url":"https://www.sec.gov/Archives/edgar/data/1708599/0001413350-26-000002.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel